Abstract:Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, and ethnic diversity has been reported in its manifestation. This review addressed phenotype and genetic studies in Asian women with PCOS. Generally, East Asians are less hirsute, and the hirsutism score cutoff is lower than the Caucasian counterpart. It is not clear whether there are any significant differences in the prevalence or severity of irregular menstruation (IM) or characteristics of polycystic ovary (PCO) acr… Show more
“…8 Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and irregular menstruation, and the polycystic ovary subgroup is relatively common in Asian ethnicities. 10 In addition, genetic studies on PCOS reported that there is polymorphism in follicular stimulating hormone receptor gene, which plays key role in a menstrual cycle. 11,12 These might be the reasons for the higher risk of irregular menstrual cycles in Asian ethnicities.…”
Section: Introductionmentioning
confidence: 99%
“…The Nurse's Health Study II showed that women of Asian ethnicity had a higher risk of irregular menstrual cycles than that of white people (PR: 1.38, 95% confidence interval [CI]: 1.19‐1.61) 8 . Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and irregular menstruation, and the polycystic ovary subgroup is relatively common in Asian ethnicities 10 . In addition, genetic studies on PCOS reported that there is polymorphism in follicular stimulating hormone receptor gene, which plays key role in a menstrual cycle 11,12 .…”
The menstrual cycles is controlled by the cyclical secretion of reproductive hormones, including luteinizing hormone, follicle-stimulating hormone, estrogen, and progesterone, which are regulated by the hypothalamus-pituitary-ovarian axis. 1 The absence of menses ≥3 months is diagnosed as secondary amenorrhea. Over 50% of secondary amenorrhea
“…8 Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and irregular menstruation, and the polycystic ovary subgroup is relatively common in Asian ethnicities. 10 In addition, genetic studies on PCOS reported that there is polymorphism in follicular stimulating hormone receptor gene, which plays key role in a menstrual cycle. 11,12 These might be the reasons for the higher risk of irregular menstrual cycles in Asian ethnicities.…”
Section: Introductionmentioning
confidence: 99%
“…The Nurse's Health Study II showed that women of Asian ethnicity had a higher risk of irregular menstrual cycles than that of white people (PR: 1.38, 95% confidence interval [CI]: 1.19‐1.61) 8 . Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and irregular menstruation, and the polycystic ovary subgroup is relatively common in Asian ethnicities 10 . In addition, genetic studies on PCOS reported that there is polymorphism in follicular stimulating hormone receptor gene, which plays key role in a menstrual cycle 11,12 .…”
The menstrual cycles is controlled by the cyclical secretion of reproductive hormones, including luteinizing hormone, follicle-stimulating hormone, estrogen, and progesterone, which are regulated by the hypothalamus-pituitary-ovarian axis. 1 The absence of menses ≥3 months is diagnosed as secondary amenorrhea. Over 50% of secondary amenorrhea
“…Despite confounding factors that could not be excluded from the study, such findings may indicate that different genetic components could play different extends of roles in the disease development, leading to different manifestations. For instance, it was reported that East Asian patients with PCOS were more likely to have diabetes compared with Caucasian patients [56]. Thus, continuous genome-based studies are needed to personalize the diagnosis and management of PCOS across different ethnicities.…”
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) in hormone metabolism pathways might cause metabolic disturbances and contribute to the development of polycystic ovary syndrome (PCOS) and ovarian cancer, but the published studies were inconsistent. The aim of this study was to evaluate the MTHFR C677T (rs1801133) and A1298C (rs1801131) gene polymorphisms in the risk of PCOS and ovarian cancer by meta-analysis. A comprehensive electronic search was conducted in databases for studies published from 1995 to 2020. The pooled ORs were calculated by Revman 5.2 software. Twenty-nine articles including 45 case-control studies were included. We found that MTHFR C677T polymorphisms were correlated with elevated PCOS risk (TT vs. CT+CC: OR=1.41, 95%CI=1.20-1.67; TT+CT vs. CC: OR=1.54, 95%CI=1.07-2.22; CT vs. CC+TT: OR=1.18, 95%CI-1.04-1.33; TT vs. CC: OR=1.47, 95%CI=1.03-2.11; T vs. C: OR=1.25, 95%CI=1.06-1.47), which were more obvious in Middle Eastern subgroup. MTHFR A1298C polymorphisms were also associated with overall PCOS susceptibility (CC vs. AC+AA: OR=2.55, 95%=1.61-4.03; CC+AC vs. AA: OR=1.84, 95%CI=1.04-3.28; CC vs. AA: OR=2.66, 95%CI=1.68-4.22; C vs. A: OR=1.67, 95%CI=1.03-2.71), which were mainly reflected in Asian subjects. For ovarian cancer, MTHFR C677T polymorphisms were only related with elevated ovarian cancer risk in Asian population, while no significant association was found for A1298C polymorphisms. This meta-analysis suggested that MTHFR C677T and MTHFR A1298C polymorphisms were correlated with elevated PCOS risk. MTHFR C667T only posed a higher risk for ovarian cancer in Asians instead of other populations, while MTHFR A1298C polymorphisms were not related to ovarian cancer risk. Further studies are needed to validate the conclusion.
“…Recent meta-systemic analyses pointed out at large trials variation (5-13%) in the overall prevalence of PCOS, according to the National Institutes of Health, Rotterdam and Androgen Excess Society criteria. [1][2][3] These variations are due to problematic definitions of the PCOS syndrome and its phenotypic expression (e.g. hyperandrogenism to hirsutism, anovulation to infertility, amenorrhea to irregular/heavy uterine bleeding, insulin resistance to obesity), as well as its diagnostic cut-off between different study size cohorts and ethnicities in an unselected population, and these criteria contribute in patients' PCOS diagnosis bias.…”
Section: Introductionmentioning
confidence: 99%
“…hyperandrogenism to hirsutism, anovulation to infertility, amenorrhea to irregular/heavy uterine bleeding, insulin resistance to obesity), as well as its diagnostic cut-off between different study size cohorts and ethnicities in an unselected population, and these criteria contribute in patients' PCOS diagnosis bias. [1][2][3][4] Hence, identifying the correct PCOS etiology is pivotal in adopting the best clinical practices.…”
Polycystic ovary syndrome (PCOS) is a disorder characterized mainly by a disruption of androgen secretion or endocrine feedback mechanism dysfunction occurring subtlety during adolescence and progressively impairing the ovarian folliculogenesis which affects preponderantly women of reproductively active age. Most of the reproductive active period of women is hampered by this condition, thereof reducing their fertility and causing metabolic disturbances. Traditional Chinese Medicine principles have been historically settled to develop Chinese Herbal Medicine formulas designed to treat various ailments including reproductive disorders. This study addresses the mechanisms of action of Jia-Wei-Xiao-Yao-San formula by examining the functional predicted PCOS-related targets networks first enriched by STITCH chemical interactions and then analyzed by STRING protein interactions database. Using the highest confidence interaction score as a screening binding parameter, we obtained a total of 274 PCOS-related targets interacting with 58 bioactive compounds from the formula and 22 PCOS-related drugs interacting with a total of 133 PCOS-related targets. Our analysis identified a total of 84 common PCOSrelated targets shared by both the formula and the PCOS-related drugs and demonstrate the predicted PCOS-related protein-protein interaction network resulting in various KEGG pathways. These findings indicated the formula functionality role preponderantly in cholesterol metabolism, ovarian steroidogenesis, peroxisome proliferator-activated receptors, and adipocytokine signaling pathway. Numerous compounds identified here are known to have high binding interactions with PCOS-related targets. Our methodological approach demonstrates that both the drugs-PCOS-related targets network support Jia-Wei-Xiao-Yao-San formula as an appropriate Traditional Chinese Medicine to treat at least the symptoms associated with PCOS manifestations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.